Publication at First Faculty of Medicine |
2014
Abstract
Patients suffering from malignant diseases are at risk of opportunistic infections most often caused by candida, aspergillus and zygomyces species. Echinocandins represent the drug of first choice in the treatment of invasive candidiasis, while voriconazole is indicated as first line treatment in aspergillosis and amphotericin B or rather its lipid forms are indicated in cases of mucormycosis.